NIH May 1 (Reuters) – Neurotrope Inc said on Monday the smaller dose of its experimental Alzheimer’s drug met the main goal in a small mid-stage study, but shares tumbled 36 percent in premarket trading as investors were not impressed with the data. In the Neurotrope trial, two doses of Bryostatin-1 were tested against a […]
